Analytical Data
-
Gene name
LAMR1
- Application
-
Alternative Names
RPSA; LRP; 37LRP; p40; 40S ribosomal protein SA; 37 kDa laminin receptor precursor; Colon carcinoma laminin-binding protein; Multidrug resistance-associated protein MGr1-Ag
-
Species
Pig
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q4GWZ2
-
Expression Region
Met1~Ser295
-
Molecular Weight
28kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LAMR1, or the Lung Angiotensin II Type 1 Receptor Modulator 1, is a protein primarily studied for its role in regulating angiotensin II signaling pathways, which are crucial in cardiovascular and renal physiology. Recent research has highlighted the involvement of LAMR1 in various pathophysiological conditions, including hypertension, heart failure, and kidney diseases, making it a significant target for therapeutic intervention. Understanding the molecular mechanisms of LAMR1, through the development of recombinant proteins, has become essential for elucidating its biological functions and potential as a drug target. The production of LAMR1 recombinant proteins allows for the examination of its interactions with other cellular components and the investigation of its signaling pathways in controlled laboratory settings. This research not only contributes to the fundamental understanding of angiotensin II receptor biology but also paves the way for the development of novel therapeutic strategies aimed at modulating this pathway, offering potential benefits for patients suffering from cardiovascular disease and other related disorders. Hence, the study of LAMR1 and its recombinant forms is integral to advancing our knowledge in molecular biology, improving therapeutic approaches, and enhancing clinical outcomes for various diseases.
